162 results on '"Wernli, Karen"'
Search Results
2. Emergency Department Use in Adolescent and Young Adult Cancer Early Survivors from 2006 to 2020
3. Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer
4. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care
5. Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022
6. Response to Omoleye, Esserman, Olufunmilayo
7. Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022
8. 1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
9. Antibody response to symptomatic infection with SARS-CoV-2 Omicron variant viruses, December 2021—June 2022
10. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density
11. Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021–June 2022
12. Incidence and Survival for Patients Diagnosed With Breast, Colorectal, and Lung Cancer in an Integrated System
13. Work Attendance during Acute Respiratory Illness Before and During the COVID-19 Pandemic, United States, 2018-2022
14. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system
15. Supplementary Figure S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
16. Supplementary Figure S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
17. Supplementary Figure S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
18. Supplementary Methods from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
19. Supplementary Table S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
20. Supplementary Figure S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
21. Supplementary Figure S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
22. Supplementary Figure S3 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
23. Supplementary Table S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
24. Supplementary Methods from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
25. Supplementary Table S2 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
26. Supplementary Table S1 from Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
27. Evaluating reduced effectiveness after repeat influenza vaccination while accounting for confounding by recent infection and within-season waning
28. Abstract P5-04-01: Screening Patterns of Mammography and Breast Magnetic Resonance Imaging Following Cancer Genetic Testing in an Integrated Health Care System
29. Prioritizing Screening Mammograms for Immediate Interpretation and Diagnostic Evaluation on the Basis of Risk for Recall
30. Breast Cancer Screening: Evidence and Recommendations
31. Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status
32. Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March–November 2020
33. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor–Positive Breast Cancer
34. Performance of Statistical and Machine Learning Risk Prediction Models for Surveillance Benefits and Failures in Breast Cancer Survivors
35. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
36. Women's Breast Cancer Screening Confidence by Screening Modality and Breast Density: A Breast Cancer Surveillance Consortium Survey Study
37. Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
38. Is Breast MRI Better at Finding Second Breast Cancers than Mammograms Alone for Breast Cancer Survivors?
39. Decision quality and regret with treatment decisions in women with breast cancer: Pre-operative breast MRI and breast density
40. Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza
41. Simulation modeling as a tool to support clinical guidelines and care for breast cancer prevention and early detection in high-risk women.
42. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic
43. Breast Density Knowledge in a Screening Mammography Population Exposed to Density Notification
44. Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016
45. Challenges and Opportunities of Epidemiological Studies to Reduce the Burden of Cancers in Young Adults
46. Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
47. Cross-ancestry Genome-wide Association Studies of Sex Hormone Concentrations in Pre- and Postmenopausal Women
48. Patient Perspectives on Longitudinal Adherence to Lung Cancer Screening
49. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years
50. Mammography adherence in relation to function-related indicators in older women
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.